Consistent with this view, the highly successful live yellow fever vaccine YF-17D activates multiple PRRs that collectively define the cytokine profile and magnitude of both CD4 and CD8 T cell responses as well as antibody responses [5–7]. The gene discussed is CD4; the disease is viral infectious disease.